NYSEARCA:BBC Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News $24.83 +0.21 (+0.85%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$24.81▼$24.8350-Day Range$21.24▼$25.3852-Week Range$17.77▼$29.08Volume1,873 shsAverage Volume2,340 shsMarket Capitalization$12.41 millionAssets Under Management$12.29 millionDividend Yield0.00%Net Expense Ratio0.79% ProfileProfileChartHeadlinesHoldingsProfileChartHeadlinesHoldings About Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.Read More Receive BBC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBC ETF News HeadlinesMay 8, 2023 | finance.yahoo.com4 Best-Performing ETF Areas of Last WeekApril 2, 2023 | finance.yahoo.comBiotech Stocks Languish After Dismal Quarter of Clinical ResultsJune 3, 2023 | Vantage Point (Ad)We Called (ARWR) In Advance, Which Stocks Are Next?Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE. March 29, 2023 | bbc.comGwyneth Paltrow ski crash trial: Who's whoFebruary 23, 2023 | cbsnews.comClinical trial helping stroke victims regain functionsJanuary 25, 2023 | bizjournals.comRockville biotech RegenxBio launches clinical trial in muscular dystrophyJanuary 9, 2023 | benzinga.comTrevena Enrolls First Subject in TRV045 Proof-of-Concept Trial Evaluating S1PR Mechanism of Action and Target EngagementSeptember 27, 2022 | uk.finance.yahoo.com5 Best Areas of Q3 of 2022 & Their Top ETFsJune 3, 2023 | Vantage Point (Ad)Instantly Find Hidden Trade OpportunitiesThere’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market. July 1, 2022 | msn.comBest Performing ETFs For June 2022See More Headlines BBC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Clinical Trials ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBC Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Clinical Trials Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings125 Fund Statistics Assets Under Management$12.29 million Average Daily Volume$2,946.40 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares500,000Beta1.08 Creation Unit50,000 Creation Fee$500.00 Virtus LifeSci Biotech Clinical Trials ETF ExpensesTypeBBCHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.54%0.52%0.50%0.49%Other Expenses0.00%0.41%0.48%0.64%0.51%Total Expense0.79%0.69%0.67%0.74%0.66%Fee Waiver0.00%-0.39%-0.49%-0.69%-0.52%Net Expense0.79%0.60%0.58%0.57%0.55% Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings & ExposureTop 10 BBC HoldingsMadrigal Pharmaceuticals(NASDAQ:MDGL)Holding Weight: 4.41%TG Therapeutics(NASDAQ:TGTX)Holding Weight: 3.19%Reata Pharmaceuticals(NASDAQ:RETA)Holding Weight: 2.43%Bny Mellon Cash Reserve UsdHolding Weight: 2.37%Protagonist Therapeutics(NASDAQ:PTGX)Holding Weight: 2.00%Morphic(NASDAQ:MORF)Holding Weight: 1.60%Summit Therapeutics(NASDAQ:SMMT)Holding Weight: 1.59%Prometheus Biosciences(NASDAQ:RXDX)Holding Weight: 1.50%IVERIC bio(NASDAQ:ISEE)Holding Weight: 1.40%Arcturus Therapeutics(NASDAQ:ARCT)Holding Weight: 1.18%BBC Sector ExposureBBC Industry ExposureFull Holdings Details Similar ETFsGlobal X MSCI China Health Care ETFNYSEARCA:CHIHDirexion Daily Pharmaceutical & Medical Bull 3X SharesNYSEARCA:PILLVirtus LifeSci Biotech Products ETFNYSEARCA:BBPProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISHorizon Kinetics Medical ETFNASDAQ:MEDX BBC ETF - Frequently Asked Questions How have BBC shares performed in 2023? Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $24.99 on January 1st, 2023. Since then, BBC stock has decreased by 0.6% and is now trading at $24.8282. View the best growth stocks for 2023 here. What does BBC invest in? Virtus LifeSci Biotech Clinical Trials ETF is a equity fund issued by Virtus. BBC focuses on health care investments and follows the LifeSci Biotechnology Clinical Trials Index. The fund's investments total to approximately $12.29 million assets under management. What stocks does Virtus LifeSci Biotech Clinical Trials ETF hold? BBC invests in 125 holdings. Some of the stocks in their portfolio include Madrigal Pharmaceuticals (MDGL), TG Therapeutics (TGTX), Reata Pharmaceuticals (RETA), Protagonist Therapeutics (PTGX), Morphic (MORF), Summit Therapeutics (SMMT), Prometheus Biosciences (RXDX), IVERIC bio (ISEE), Arcturus Therapeutics (ARCT) and Merus (MRUS). What is the management fee for Virtus LifeSci Biotech Clinical Trials ETF? Virtus LifeSci Biotech Clinical Trials ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBC is 0.79%. What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ). What is Virtus LifeSci Biotech Clinical Trials ETF's stock symbol? Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BBC." How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF? Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today? One share of BBC stock can currently be purchased for approximately $24.83. How much money does Virtus LifeSci Biotech Clinical Trials ETF make? Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) has a market capitalization of $12.41 million. This page (NYSEARCA:BBC) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.